ESC 365 - Major bleeding complication in patients with CS on Impella and undergoing Impella assisted high risk percutaneous coronary intervention. Results of IMPELLA PL registry.

Open Access

Major bleeding complication in patients with CS on Impella and undergoing Impella assisted high risk percutaneous coronary intervention. Results of IMPELLA PL registry.

Session: Mechanical circulatory devices: cardiogenic shock & beyond

Topic: Percutaneous Coronary Intervention (PCI)

Speaker: Doctor K. Pilawska (Warsaw, PL)

Event: EAPCI Summit 2026

Congress Presentation

Add to my library

About the speaker

Doctor Katarzyna Pilawska

Medical University in Warsaw, Warsaw (Poland)

0 follower

6 more presentations in this session

Efficacy and safety of cangrelor on top of anticoagulation in patients with myocardial infarction related cardiogenic shock or cardiac arrest receiving va ecmo: preliminary data from a phase 2 trial

Speaker: Doctor P. Nardelli (Milan, IT)

Mechanical circulatory support with microaxial flow pump for high-risk PCI: a comparative analysis in left main disease

Speaker: Doctor G. Botti (Milan, IT)

One-year outcomes of high-risk percutaneous coronary interventions with versus without mechanical circulatory support: propensity score-matched analysis.

Speaker: Miss E. Blazejowska (Warsaw, PL)

Evaluation of LVEPD change during high-risk PCI with and without impella support (elvis)- one-year follow-up

Speaker: Doctor A. Gjata (Trier, DE)

Use of pulmonary artery catheters during ImpellaTM-protected high risk percutaneous coronary intervention: a single centre experience

Speaker: Doctor K. Wales (Sydney, AU)

Access the full session

Mechanical circulatory devices: cardiogenic shock & beyond

Speakers: Doctor K. Pilawska, Doctor P. Nardelli, Doctor G. Botti, Miss E. Blazejowska, Doctor A. Gjata...

About the event

EAPCI Summit 2026

19 February - 20 February 2026

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources